Nasal spray

A technology of wetting agent and nasal mucosa, which is applied in the field of pharmaceuticals without sympathomimetic drugs, and can solve the problems of short solution residence time and insufficient degree of relief

Active Publication Date: 2013-05-08
可利威玛瑟巴施有限公司
View PDF15 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Due to the short residence time of the solution, the solution has to be administere

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nasal spray
  • Nasal spray
  • Nasal spray

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030]

Embodiment 2

[0032]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a medicinal product which is free from sympathomimetics, has an advantageous effect on the nasal mucosa in case of common colds, hay fever, dry nose and sympathomimetic dependencies, and is provided in the form of a nasal spray, a nasal douche or nasal drops.

Description

technical field [0001] The present invention relates to sympathomimetic-free medicinal products in the form of nasal sprays, nasal rinses or nasal drops for the treatment of common colds, hay fever or other rhinitis, dry nose and / or sympathomimetic dependence ( dependence) has a beneficial effect on the nasal mucosa. Background technique [0002] In the common cold (catarrhal rhinitis), hay fever, other rhinitides or dry nose, the nasal mucosa undergoes swelling. To date, treatment with topical sympathomimetic agents, usually in the form of nasal drops or nasal sprays, has been used to achieve a reduction in mucosal swelling. However, sympathomimetics have many undesirable side effects due to absorption and may cause palpitations and respiratory disturbances. Furthermore, they dry out the nasal mucosa and when administered chronically, permanent damage to the epithelium of the nasal mucosa may occur. This sympathomimetic drug dependence is called drug-induced rhinitis (Ap...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/61A61K36/53A61K36/534A61K31/74A61K33/14A61P11/00
CPCA61K36/534A61K31/164A61K9/08A61K36/61A61K31/045A61K36/53A61K33/14A61K31/74A61K9/0043A61K47/38A61P11/00A61P11/02A61P29/00A61P37/08A61K2300/00
Inventor D.席尔迪特
Owner 可利威玛瑟巴施有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap